Since launch in 2009, SI-BONE’s iFuse Implant System® has been used in >20,000 procedures worldwide, by >1,100 surgeons.
Extensive clinical evidence published over several years is cited as an influence on payors such as Medicare, Medicaid, Blue Cross Blue Shield of Michigan, Geisinger, Kaiser Permanente and United Healthcare to cover the procedure.
SI-BONE launched iFuse in Australia and New Zealand in April 2016, where it is distributed by Device Technologies. During 1Q16, first iFuse procedures were performed in Israel, Kuwait and Saudi Arabia. The product is now available in 25 countries, including 21 in Europe and the Middle East.
Since launch in 2009, SI-BONE's iFuse Implant System® has been used in >20,000 procedures worldwide, by >1,100 surgeons.
Extensive clinical evidence published over several years is cited as an influence on payors such as Medicare, Medicaid, Blue Cross Blue Shield of Michigan, Geisinger, Kaiser Permanente and United Healthcare to cover...
Since launch in 2009, SI-BONE’s iFuse Implant System® has been used in >20,000 procedures worldwide, by >1,100 surgeons.
Extensive clinical evidence published over several years is cited as an influence on payors such as Medicare, Medicaid, Blue Cross Blue Shield of Michigan, Geisinger, Kaiser Permanente and United Healthcare to cover the procedure.
SI-BONE launched iFuse in Australia and New Zealand in April 2016, where it is distributed by Device Technologies. During 1Q16, first iFuse procedures were performed in Israel, Kuwait and Saudi Arabia. The product is now available in 25 countries, including 21 in Europe and the Middle East.
Copy to clipboard 
